Labeling package insert, labelingcontainercarton labels. Accelerated approval was granted for fl and sll based on. Highlights of prescribing information perforation can occur. The incidence of grade 3 to 5 hemorrhagic events was 5% in cabometyx. Severe and fatal hemorrhages occurred with cabometyx. Highlights of prescribing information antiplatelet. Carefirst bluecross blueshield is the shared business name of carefirst of maryland, inc. Cometriq increased the incidence of thrombotic events venous thromboembolism. Zykadia is a prescription medicine that is used to treat people with nonsmall cell lung cancer nsclc that. Talk to your healthcare provider about the risks and benefits of using this medication when pregnant see cometriq and pregnancy. Fda grants regular approval to cabometyx for firstline. Cometriq is prescribed to treat medullary thyroid cancer in adults. Eocco010 description cabozantinib cabometyx, cometriq is an orally administered tyrosine kinase inhibitor of ret, met, vegfr123, kit, trkb, flt3, and tie2.
Cometriq cabozantinib capsules 100 mg daily dose blister cards each 100 mg daily dose contains a combination of one swedish orange 80 mg and one grey 20 mg capsule. Cabometyx cabozantinib tablets and cometriq cabozantinib capsules are not bioequivalent and should not be used interchangeably see section 5. Wound healing problems have happened in some people who take cabometyx. Cometriq while maintaining optimal therapeutic outcomes. It is a small molecule inhibitor of the tyrosine kinases cmet and vegfr2, and also inhibits axl and ret. Coadministration with a strong cyp3a4 inhibitor increased the exposure of cabozantinib, which may increase the. Cometriq cabozantinib capsules are supplied as printed hard gelatin capsules containing cabozantinib smalate equivalent to 20 mg or 80 mg cabozantinib and the following inactive ingredients. Cometriq may react with a number of other medications see cometriq drug interactions. Full text the treatment landscape in thyroid cancer. Talk to your healthcare provider about the risks and benefits of using this medication when pregnant see. Please see the accompanying full prescribing information for cometriq. Unresectable locoregional disease that is symptomatic or structurally progressive.
Instruct patients not to eat for at least 2 hours before and at least 1 hour after taking cabometyx. If patients must be coadministered a strong cyp3a4 inducer, based on pharmacokinetic studies, a torisel dose increase from 25 mgweek up to 50 mgweek should be considered. Cometriq cabozantinib is indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer mtc. Oncaspar pegaspargase is indicated as a component of a multiagent chemotherapeutic regimen for the treatment of pediatric and adult patients with. Official site for healthcare professionals nexavar. See full prescribing information for complete boxed. If a patient must switch from cabozantinib capsules to cabozantinib tablets, the patient should continue at a cabometyx dose not to exceed 60 mg or the current cometriq dose whichever is lower.
Cometriq 80mg gelatin capsules are swedish orange with xl184 80mg printed in black on the body of the capsule. Stivarga regorafenib is a prescription medicine used to treat people with. Your healthcare provider should tell you when you may start taking cabometyx again after surgery. Package label carton 100 mg daily dose of cometriq. Cabozantinib smalate salt is a white to offwhite solid that is practically insoluble in aqueous media. Do not administer cometriq to patients with a recent history of hemorrhage, including hemoptysis, hematemesis, or melena. Eocco010 description cabozantinib cabometyx, cometriq is an orally administered tyrosine kinase inhibitor of ret, met. Cabozantinib, sold under the brandname cabometyx and cometriq, is a medication used to treat medullary thyroid cancer and a second line treatment for renal cell carcinoma among others. It is an oral receptor tyrosine kinase inhibitor for more detail. Blinatumomab is a bispecific cd19directed cd3 tcell engager that binds to cd19 expressed on the surface of cells of blineage origin and. Cometriq is a prescription medicine used to treat people with medullary thyroid cancer that has spread to other parts of the body. This medicinal product is subject to additional monitoring. It is not known if cometriq is safe and effective in children.
Cabometyx is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma rcc who have received prior anti angiogenic therapy. Plavix has been evaluated for safety in more than 54,000 patients, including over 21,000 patients treated for one year or more. Protein in your urine and possible kidney problems. Please scroll down to see important safety information for cometriq and click here to see the full prescribing information. The antiangiogenic ceiling in hepatocellular carcinoma. Cabometyx cabozantinib is indicated for the treatment of patients with. On december 19, 2017, the food and drug administration granted regular approval to cabozantinib cabometyx, exelixis, inc. Cometriq cabozantinib 100mg dailydose pack 1 dose pack 56 capsules per 28 days cometriq cabozantinib 140mg dailydose pack 1 dose pack 112 capsules per 28 days approval criteria requests for cometriq cabozantinib capsules may be approved if the following criteria are met. Call your doctor for medical advice about side effects.
Monitor for the development of severe diarrhea or colitis. In some cases, health care professionals may use the generic name cabozantinib when referring to the trade name cometriq. Authorization of 24 months may be granted to members prescribed cometriq for medullary thyroid cancer whose disease meets one of the following. It also offers an explanation of how this drug works. These tyrosine kinases are involved in both normal cellular function and pathologic processes, such as. Highlights of prescribing information these highlights do not. Erivedge vismodegib capsules, for oral use initial u. Cometriq 20mg gelatin capsules are grey with xl184 20mg printed in black on the body of the capsule. In 2012 cabozantinib in its capsule formulation was. Side effects of cometriq cabozantinib capsules, warnings. Asymptomatic distant metastases if structurally progressive and unresectable iii. This is not a complete list of side effects and others may occur.
It is not known if zykadia is safe and effective in. Cometriq fda prescribing information, side effects and uses. The clinically important adverse reactions observed in trials comparing plavix plus aspirin to placebo plus aspirin and trials comparing plavix alone to. For disease that is of predominantly clear cell histology, cometriq will be used for disease that has progressed on prior antiangiogenic therapy e. Cometriq is the trade name for the generic chemotherapy drug cabozantinib. If previously receiving 60 mg daily dose, resume treatment at 40 mg daily. Cometriq cabozantinib is a cancer medicine indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer mtc 1,2. Highlights of prescribing information these highlights do. Coadministration with a strong cyp3a4 inhibitor increased the exposure of cabozantinib, which may increase the risk of exposurerelated adverse reactions. Coronavirus covid19 update at exelixis, we remain committed to serving the needs of people who take cabometyx. Cometriq is a prescription medicine used to treat people with medullary thyroid cancer mtc that has spread to other parts of the body called metastatic mtc it is not known if cometriq is safe and effective in children. Administration of a strong cyp3a4 inhibitor, ketoconazole to healthy subjects increased singledose plasma cabozantinib exposure by 38% cabometyx.
This emedtv web page discusses why cometriq is only used when the cancer has progressed to other areas of the body. Cabometyx, inncabozantinib european medicines agency. Do not substitute cabometyx tablets with cabozantinib capsules. Highlights of prescribing information palmarplantar. Cometriq, cabometyx cabozantinib dosing, indications. Feb 14, 2020 cabozantinib smalate salt is a white to offwhite solid that is practically insoluble in aqueous media. Is caused by a defect in a gene called anaplastic lymphoma kinase alk and has spread to other parts of the body. Highlights of prescribing information cardiac dysfunction. Fatal andor serious and severe diarrhea or colitis occurred in 14% to 19% of zydeligtreated patients. Zivaflibercept acts as a soluble receptor that binds to human vegfa equilibrium dissociation constant kd of 0. Tell your healthcare provider if you plan to have any surgery before or during treatment with cabometyx. You should stop taking cabometyx at least 3 weeks before planned surgery.
Monitor hepatic function prior to and during treatment see warnings and precautions 5. Oncology related including new drugs, antagonists, etc. Cabometyx cabozantinib is indicated for the treatment of patients with hepatocellular carcinoma hcc who have been previously treated with sorafenib. Highlights of prescribing information tafinlar with. Side effects of cometriq cabozantinib capsules, warnings, uses. Cometriq treatment results in an increased incidence of treatmentemergent hypertension with joint national committee on prevention, detection, evaluation, and treatment of high blood pressure modified jnc criteria stage 1 or 2 hypertension identified in 61% in cometriqtreated patients compared with 30% of placebotreated patients in the randomized trial. History of serious thrombosis with prior lasparaginase therapy. Cometriq has been shown to inhibit the activity of met. Although patients with thyroid cancer generally fare well, there is a subset for which this is not necessarily true. Severe and sometimes fatal hepatotoxicity has occurred in clinical trials. Feb 14, 2020 nearly all cometriq treated patients 96% vs.
Hepatotoxicity severe and sometimes fatal hepatotoxicity has occurred in clinical trials see warnings and precautions 5. Unresectable locoregional disease that is symptomatic or structurally progressive ii. History of serious hypersensitivity reactions, including anaphylaxis, to oncaspar or to any of the excipients. If you have difficulty viewing the document below, please click here to view the full prescribing information, including the boxed warning.
Highlights of prescribing information when administering. Interrupt and then reduce or discontinue stivarga for hepatotoxicity as manifested by elevated liver. Start with nexavar sorafenib as a foundation for a systemic treatment plan 15. The clinically important adverse reactions observed in trials comparing plavix plus aspirin to placebo plus aspirin and trials comparing plavix alone to aspirin alone are discussed below. The printed package leaflet of the medicinal product must state the name and address of the.
Gastrointestinal perforations occurred in 3% and fistula formation in 1% of. Cometriq is a pregnancy category d medication, which means it may harm an unborn child. Cabometyx cabozantinib is contraindicated in patients who are. Dec 23, 2019 cometriq 20mg gelatin capsules are grey with xl184 20mg printed in black on the body of the capsule. Cabozantin cabometyx, cometriq eocco policy policy type. Nccn clinical practice guidelines in oncology nonsmall cell lung cancer version 3. Cabometyx cabozantinib tablets and cometriq cabozantinib capsules are not. Refer to the dabrafenib prescribing information for recommended dabrafenib dosing information. It is a medicine used to treat medullary thyroid cancer, a rare type of. Our cometriq cabozantinib side effects drug center provides a comprehensive view of available drug information on the potential side effects when taking this medication. Tell your healthcare provider right away if you have rashes, redness, pain, swelling, or blisters on the palms of your hands or soles of your feet. Highlights of prescribing information perforation can. The most common laboratory abnormalities incidence.
Cometriq is indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer mtc. Handfoot skin reactions are common with cometriq and can be severe. Cabozantinib in patients with advanced and progressing. The active substance in cometriq, cabozantinib, is a tyrosine kinase inhibitor. For disease that is of nonclear histology, cometriq will be used as firstline systemic therapy. Cometriq is a cancer medicine that contains the active substance cabozantinib smalate. The use of concomitant strong cyp3a4 inducers should be avoided e.
1058 654 76 15 662 1441 1298 1208 452 93 899 984 1053 575 1341 1121 814 863 1183 626 609 232 1009 399 1283 915 593 1087 225 1359 276 725 628 1035 604 888 315